SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-21-175250
Filing Date
2021-05-27
Accepted
2021-05-27 16:02:24
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d140236ddefa14a.htm DEFA14A 18933
2 GRAPHIC g140236dsp002.jpg GRAPHIC 237587
3 GRAPHIC g140236dsp003.jpg GRAPHIC 169265
  Complete submission text file 0001193125-21-175250.txt   580513
Mailing Address 4224 CAMPUS POINT COURT SUITE 210 SAN DIEGO CA 92121
Business Address 4224 CAMPUS POINT COURT SUITE 210 SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Filer) CIK: 0001505512 (see all company filings)

IRS No.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-35670 | Film No.: 21972554
SIC: 2834 Pharmaceutical Preparations